Asston Pharmaceuticals
APLBSE

Asston Pharmaceuticals

₹73.013.01 (4.30%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
73.01
Today’s high
75.00
52 week low
65.20
52 week high
126.00
Open price
75.00
Previous close
70.00
Live volume
2,000
Lower circuit
56.00
Upper circuit
84.00

Fundamentals

Market Cap
₹60Cr
ROE
0.00%
P/E Ratio(TTM)
15.45
EPS(TTM)
4.53
P/B Ratio
1.54
Dividend Yield
0.00%
Industry P/E
45.56
Book Value
45.35
Debt to Equity
0.10
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
2025
Revenue (Cr)
₹25.61
+61.67%
Profit (Cr)
₹3.85
+183.23%
07.51522.530
2022
2023
2024
2025
Revenue growthValue
3Y CAGR+34%
Profit growthValue
3Y CAGR+227%

About

Asston Pharmaceuticals Limited is a pharmaceutical company involved in the marketing and distribution of a wide range of pharmaceutical formulations and nutraceutical products.;
CEO/MD
Ashish Narayan Sakalkar
Founded in
2019
BSE symbol
544445

Shareholding Pattern

Jan '25
Jun '25
Jul '25
Sep '25
Mar '26
Promoters
50.66%
Retail And Others
47.42%
Foreign Institutions
1.91%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹846.20
+2.70 (0.32%)
L
    H
    4,838.9434.334.44
    ₹396.85
    +15.80 (4.15%)
    L
      H
      4,031.6229.913.38
      ₹432.20
      +64.50 (17.54%)
      L
        H
        4,015.3783.9415.18
        ₹131.40
        -4.66 (3.42%)
        L
          H
          3,992.56292.22
          2026
          29
          May
          Annual Result
          Upcoming
          Release date
          2025
          14
          Nov
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks